American Society of Hirudotherapy

Lægemiddelstyrelsen — Danish Medicines Agency

DKMA · Denmark · europe

Regulatory jurisdiction profileJurisdictional reference
Medical device clearednational regulator

Denmark's medicines agency — applies EU MDR for medical devices; leech-specific regulation has not been independently verified by ASH and is presumed to follow the general MDR framework.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Denmark
Leech status
medical device cleared
Last ASH review
2026-05-25

Relevant Regulation Codes

  • Lov om medicinsk udstyr (Danish Medical Devices Act)
  • Regulation (EU) 2017/745 (MDR) — direct effect

Prescriber Requirements

  • Danish-authorised physician (læge) prescription required
  • Specific scope of nurses and other allied health professionals for hirudotherapy not independently verified by ASH

Supply Chain & GMP

EU MDR-aligned registration with DKMA; Danish-language IFU; cold chain per manufacturer specifications.

Import/Export Rules

Intra-EU free movement. Third-country imports via DKMA notification and standard CITES Appendix II paperwork; Fødevarestyrelsen (Danish Veterinary and Food Administration) for live-invertebrate clearance.

Reimbursement Context

Public health system (Regioner) covers inpatient flap-salvage indications; specific outpatient hirudotherapy reimbursement category not independently verified by ASH.

ASH Editorial Notes

Denmark's leech-specific clinical and regulatory practice has not been independently verified by ASH; the entry reflects expected EU MDR alignment. Confirm with local counsel before relying on for compliance decisions.

Related Jurisdictions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.